Prior Asymptomatic Parenchymal Hemorrhage Does Not Increase the Risk for Intracranial Hemorrhage after Intravenous Thrombolysis.

Mahmoud AbdelRazek,Ashkan Mowla,David Hojnacki,Wendy Zimmer,Rabab Elsadek,Noureldin Abdelhamid,Lobna Elsadek,Salman Farooq,Haris Kamal,Annemarie Crumlish,Peyman Shirani,Marilou Ching,Robert Sawyer

Prior Asymptomatic Parenchymal Hemorrhage Does Not Increase the Risk for Intracranial Hemorrhage after Intravenous Thrombolysis.

2015

Mahmoud AbdelRazek
Ashkan Mowla
David Hojnacki
Wendy Zimmer
Rabab Elsadek
Noureldin Abdelhamid
Lobna Elsadek
Salman Farooq
Haris Kamal
Annemarie Crumlish
Peyman Shirani
Marilou Ching
Robert Sawyer

Background: The NINDS trial demonstrated the efficacy of intravenous (IV) recombinant tissue plasminogen activator (rtPA) in improving the neurologic outcome in p

Keywords:

Asymptomatic
Fibrinolytic agent
Thrombolysis
Medicine
Tissue plasminogen activator
Intracranial Arteriovenous Malformations
Retrospective cohort study
Brain ischemia
Asymptomatic Diseases
Surgery
Single Center
Stroke

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations